Curtis K. Johnston, Pharm.D.

Group Leader, Principal Scientist II

Curtis joined Metrum in 2014 after receiving his Pharm.D. from the University at Buffalo and completing a clinical PK/PD Fellowship through UNC Chapel Hill/Quintiles. His clinical experience includes infectious disease (bacterial), oncology, and chronic liver disease (HCV and NASH). Curtis’s research interests include Bayesian methodology and the application of M&S to help inform drug development decisions.

Recent publications by this scientist

A Suite of Open-Source Tools to Guide Efficient Pharmacometric Analyses

October 28, 2022

Katherine Kay, Kyle Baron, Seth Green, Samuel Callisto, Curtis Johnston, Kyle Barrett, Devin Pastoor, Jim Rogers, Ana Ruiz-Garcia, Tim Waterhouse, Matthew Wiens, Matthew Riggs. Poster presented at 2022 American Conference on Pharmacometrics (ACoP13). 30 October – November 2 2022. Poster M-062

Download PDF

A Modeling and Simulation Primer for the Design of Pediatric Pharmacokinetic Studies

June 24, 2021

John T. Mondick and Curtis K. Johnston.  Webinar presented for American Society for Clinical Pharmacology and Therapeutics (ASCPT).  June 22, 2021.

Download PDF

A Model-Informed Drug Development (MIDD) Approach for a Low Dose of Empagliflozin in Patients with Type 1 Diabetes

April 16, 2021

Johnston CK, Eudy-Byrne RJ, Elmokadem A, Nock V, Marquard J, Soleymanlou N, Riggs MM, Liesenfeld K-H. Pharmaceutics. 2021; 13(4):485. https://doi.org/10.3390/pharmaceutics13040485

View More